Report credits Trump blueprint for 'unprecedented' action on drug prices

Perhaps not surprisingly, the US Health and Human Services (HHS) report starts with a comment congratulating the President and the plan, with the department’s Secretary Alex Azar quoted as saying: “The President’s blueprint for lower drug prices is working, drug prices are coming down, and American patients are going to see the savings in their pocketbook.”

There is reference to the ‘unprecedented number of actions taken toward structurally rebuilding this entire segment of the economy’ to lead to enduring lower prices that are sustainable, support innovation, and put American patients first in the 100 day period.

"These actions have helped bring into focus a vision for a more competitive pharmaceutical marketplace"